Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06827262 · ClinicalTrials.gov registry record

Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain

A clinical trial of Chronic Low Back Pain and Vertebrogenic Pain Syndrome, sponsored by Boston Scientific Corporation.

Recruiting
Registry status
1,500
Enrollment target
15
Study locations

NCT06827262: Recruiting study of Chronic Low Back Pain and Vertebrogenic Pain Syndrome, sponsored by Boston Scientific Corporation.

NCT06827262 is a study of Chronic Low Back Pain and Vertebrogenic Pain Syndrome that is actively recruiting participants, run by Boston Scientific Corporation. The registered enrollment target is 1,500 participants, above the 571-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (163% higher). The trial reports 15 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06827262, a study of Chronic Low Back Pain and Vertebrogenic Pain Syndrome, is actively recruiting participants, sponsored by Boston Scientific Corporation.

RECRUITING
Registry status
1,500 participants
Enrollment target
15
Study locations

Study Summary

Compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.

Primary Outcome

The Oswestry Disability Index (ODI) is a validated questionnaire of pain-related disability with total score on a scale of 0 (no disability) to 100 (complete disability). Categories for ODI total score are 0-20 (minimal disability), 21-40 (moderate disability), 41-60 (severe disability), 61-80 (crippling back pain), and 81-100 (bed-bound or exaggerating). The published minimally clinically important difference for change in ODI is 10 points.

Conditions Studied

Chronic Low Back Pain Vertebrogenic Pain Syndrome

Interventions

  • DEVICE Intracept™ Intraosseous Nerve Ablation

Study Locations (15)

Arizona

  • Flagstaff Bone & Joint - Flagstaff
  • Innovative Pain and Wellness - Phoenix

New York

  • New York Spine and Pain Specialists - Port Jefferson Station
  • University of Rochester - Rochester

California

  • MarinHealth Spine Institute - Larkspur

Connecticut

  • The Spine Wellness Center in Westport - Westport

District of Columbia

  • Washington Hospital Center - Washington D.C.

Idaho

  • North Idaho Day Surgery, LLC - Post Falls

Illinois

  • Illinois Bone and Joint Institute - Barrington

Kentucky

  • Commonwealth Pain and Spine - Lexington

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2025-03-26
Est. Completion 2034-07
Boston Scientific Corporation

280 total trials

What NCT06827262 shows while recruiting

NCT06827262 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, above the 571-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (163% higher).

The record links to 2 conditions, with Chronic Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which Intracept™ Intraosseous Nerve Ablation is the first listed.

NCT06827262 lists 15 locations in 13 states (Arizona, New York, California).

Frequently Asked Questions

What is clinical trial NCT06827262 about?

NCT06827262 is a clinical study titled "Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain". Compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.

What is the current status of trial NCT06827262?

This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2025-03-26. Estimated completion is 2034-07.

What conditions does trial NCT06827262 study?

This clinical trial studies the following conditions: Chronic Low Back Pain, Vertebrogenic Pain Syndrome.

What interventions are being tested in trial NCT06827262?

The interventions under investigation include: Intracept™ Intraosseous Nerve Ablation (DEVICE).

Who is sponsoring clinical trial NCT06827262?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06827262 being conducted?

This trial has 15 study locations across Arizona, California, Connecticut, District of Columbia, Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chronic Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06827262's enrollment target sits among peer trials

1,500 5th of 71 higher than 67 of 71 other Chronic Low Back Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00178724 · 1,500 participants

    Spinal Cord Injury Registry - North American Clinical Trials Network

  • NCT00951366 · 1,500 participants

    Preterm Lung Patient Registry

  • NCT01050504 · 1,500 participants

    Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

  • NCT02071134 · 1,500 participants

    Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06827262

Source: ClinicalTrials.gov NCT06827262, the US trial registry maintained by the National Library of Medicine. NCT06827262 (large enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.